118 related articles for article (PubMed ID: 2235202)
1. Reproductive risk assessment with occupational exposure to ribavirin aerosol.
Harrison R
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S102-5. PubMed ID: 2235202
[No Abstract] [Full Text] [Related]
2. Environmental exposure to ribavirin aerosol.
Bradley J
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S95-8. PubMed ID: 2235216
[No Abstract] [Full Text] [Related]
3. An industrial hygiene approach to controlling nonpatient exposure to ribavirin aerosol.
Kayman L
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S100-1. PubMed ID: 2235201
[No Abstract] [Full Text] [Related]
4. Care-giver protection from exposure to aerosolized pharmacologic agents. Is it necessary?
Kacmarek RM
Chest; 1991 Oct; 100(4):1104-5. PubMed ID: 1914567
[No Abstract] [Full Text] [Related]
5. Protecting hospital employees and visitors from aerosolized ribavirin.
Munzenberger PJ; Walker PC
Am J Hosp Pharm; 1994 Mar; 51(6):823-6. PubMed ID: 8010325
[No Abstract] [Full Text] [Related]
6. Ribavirin aerosol: methods for reducing employee exposure.
Arnold SD; Alonso R
AAOHN J; 1993 Aug; 41(8):382-92. PubMed ID: 8397555
[TBL] [Abstract][Full Text] [Related]
7. Use of an in-house-built ribavirin aerosol evacuation system to control incidental employee exposure to ribavirin aerosol.
Mueller BA; Waldon VK
J Clin Eng; 1996; 21(1):46-50. PubMed ID: 10154627
[TBL] [Abstract][Full Text] [Related]
8. Canada and the U.S. differ on ribavirin risk.
Healthc Hazard Mater Manage; 1991 Jun; 4(9):8. PubMed ID: 10112449
[No Abstract] [Full Text] [Related]
9. Prioritizing research questions on the safety of ribavirin in the treatment of respiratory syncytial virus infections.
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S122-3. PubMed ID: 2235207
[No Abstract] [Full Text] [Related]
10. Aerosol consensus statement--1991. American Association for Respiratory Care.
Respir Care; 1991 Sep; 36(9):916-21. PubMed ID: 10145538
[No Abstract] [Full Text] [Related]
11. Exposure of pregnant women to ribavirin-contaminated air: risk assessment and recommendations.
Ito S; Koren G
Pediatr Infect Dis J; 1993 Jan; 12(1):2-5. PubMed ID: 8417419
[No Abstract] [Full Text] [Related]
12. Ribavirin: is there a risk to hospital personnel? Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
CMAJ; 1991 Feb; 144(3):285-6. PubMed ID: 1989706
[No Abstract] [Full Text] [Related]
13. Update: ribavirin exposure.
Healthc Hazard Mater Manage; 1991 Jan; 4(4):1-4. PubMed ID: 10111085
[No Abstract] [Full Text] [Related]
14. Adverse drug reactions: United States experience. II.
Marks MI
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S117-8. PubMed ID: 2122413
[No Abstract] [Full Text] [Related]
15. Evaluation of a double-enclosure double-vacuum unit scavenging system for ribavirin administration.
Kacmarek RM; Kratohvil J
Respir Care; 1992 Jan; 37(1):37-45. PubMed ID: 10145580
[TBL] [Abstract][Full Text] [Related]
16. [Hygienic working conditions and state of health of medical workers conducting aerosol therapy].
Ashbel' SI; Mironov LA; Sinitsyna ID; Chernova LN; Filiushina ZG
Gig Tr Prof Zabol; 1979 Jun; (6):1-4. PubMed ID: 468024
[No Abstract] [Full Text] [Related]
17. Reactions to ribavirin.
Edelson PJ
Pediatr Infect Dis J; 1991 Jan; 10(1):82. PubMed ID: 2003066
[No Abstract] [Full Text] [Related]
18. Ribavirin aerosol therapy: safety for staff.
Bortolussi RA; Gold R
CMAJ; 1988 Feb; 138(3):204. PubMed ID: 3337982
[No Abstract] [Full Text] [Related]
19. The exposure of health care workers to ribavirin aerosol.
Guglielmo BJ; Jacobs RA; Locksley RM
JAMA; 1989 Apr; 261(13):1880-1. PubMed ID: 2926922
[No Abstract] [Full Text] [Related]
20. Assessing exposures of health-care personnel to aerosols of ribavirin--California.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Sep; 37(36):560-3. PubMed ID: 3137440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
